On heels of Lumakras da­ta drop, new KRAS idea emerges; Bris­tol My­ers, Ab­b­Vie, Ru­bius head­line busy week of re­struc­tur­ing; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

Long­time End­points read­ers would know that every year, ed­i­tor-in-chief John Car­roll hand­picks a group of up-and-com­ing pri­vate biotech up­starts that are promis­ing to shake up the field — or fail loud­ly. This year’s End­points 11 will be an­nounced against a dra­mat­ic back­drop, and we’ll be pre­sent­ing the awards in per­son. Join us for the cel­e­bra­tion — fea­tur­ing a fire­side chat with No­bel Prize lau­re­ate Phillip Sharp — in Boston.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER